Skip to content

Clinical trials

Phase 3 Hemorrhage trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Phase: Phase 3 Country / region: Italy Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20072
20081
20091
20102
20141
20191
20204
20221
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting4
Unknown status3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Idorsia Pharmaceuticals Ltd.2
Pfizer2
Takeda2
University of Milan2
Assistance Publique - Hôpitaux de Paris1
Azienda Ospedaliera San Camillo Forlanini1
Boehringer Ingelheim1
Clinica Mediterranea1
Population Health Research Institute1
SFJ Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage16
Autoimmune Diseases2
Blood Platelet Disorders2
Cytopenia2
Hematologic Diseases2
Hemophilia A2
Hemophilia B2
Hemorrhagic Disorders2
Immune System Diseases2
Pulmonary Embolism2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.